243 related articles for article (PubMed ID: 28583901)
1. Highly efficient delivery of potent anticancer iminoquinone derivative by multilayer hydrogel cubes.
Xue B; Wang W; Qin JJ; Nijampatnam B; Murugesan S; Kozlovskaya V; Zhang R; Velu SE; Kharlampieva E
Acta Biomater; 2017 Aug; 58():386-398. PubMed ID: 28583901
[TBL] [Abstract][Full Text] [Related]
2. Intracellular Degradable Hydrogel Cubes and Spheres for Anti-Cancer Drug Delivery.
Xue B; Kozlovskaya V; Liu F; Chen J; Williams JF; Campos-Gomez J; Saeed M; Kharlampieva E
ACS Appl Mater Interfaces; 2015 Jun; 7(24):13633-44. PubMed ID: 26028158
[TBL] [Abstract][Full Text] [Related]
3. Peptide-Functionalized Hydrogel Cubes for Active Tumor Cell Targeting.
Xue B; Kozlovskaya V; Sherwani MA; Ratnayaka S; Habib S; Anderson T; Manuvakhova M; Klampfer L; Yusuf N; Kharlampieva E
Biomacromolecules; 2018 Oct; 19(10):4084-4097. PubMed ID: 30169033
[TBL] [Abstract][Full Text] [Related]
4. pH-responsive hydrogel cubes for release of doxorubicin in cancer cells.
Kozlovskaya V; Chen J; Tedjo C; Liang X; Campos-Gomez J; Oh J; Saeed M; Lungu CT; Kharlampieva E
J Mater Chem B; 2014 May; 2(17):2494-2507. PubMed ID: 32261419
[TBL] [Abstract][Full Text] [Related]
5. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
Qu J; Zhao X; Ma PX; Guo B
Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled hydrogel nanocube for stimuli responsive drug delivery and tumor ablation by phototherapy against breast cancer.
Arjama M; Mehnath S; Jeyaraj M
Int J Biol Macromol; 2022 Jul; 213():435-446. PubMed ID: 35661669
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
[TBL] [Abstract][Full Text] [Related]
8. Internalization of red blood cell-mimicking hydrogel capsules with pH-triggered shape responses.
Kozlovskaya V; Alexander JF; Wang Y; Kuncewicz T; Liu X; Godin B; Kharlampieva E
ACS Nano; 2014 Jun; 8(6):5725-37. PubMed ID: 24848786
[TBL] [Abstract][Full Text] [Related]
9. Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQ.
Chen D; Wang W; Qin JJ; Wang MH; Murugesan S; Nadkarni DH; Velu SE; Wang H; Zhang R
Curr Cancer Drug Targets; 2013 Jul; 13(6):651-60. PubMed ID: 23607596
[TBL] [Abstract][Full Text] [Related]
10. A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action.
Wang W; Rayburn ER; Velu SE; Chen D; Nadkarni DH; Murugesan S; Chen D; Zhang R
Breast Cancer Res Treat; 2010 Sep; 123(2):321-31. PubMed ID: 19936915
[TBL] [Abstract][Full Text] [Related]
11. The Antiproliferative Activity of Oxypeucedanin via Induction of G
Park SH; Hong JY; Park HJ; Lee SK
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979361
[TBL] [Abstract][Full Text] [Related]
12. Temperature-responsive nanogel multilayers of poly(N-vinylcaprolactam) for topical drug delivery.
Zavgorodnya O; Carmona-Moran CA; Kozlovskaya V; Liu F; Wick TM; Kharlampieva E
J Colloid Interface Sci; 2017 Nov; 506():589-602. PubMed ID: 28759859
[TBL] [Abstract][Full Text] [Related]
13. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
[TBL] [Abstract][Full Text] [Related]
14. Examination of fabrication conditions of acrylate-based hydrogel formulations for doxorubicin release and efficacy test for hepatocellular carcinoma cell.
Bayramoglu G; Gozen D; Ersoy G; Ozalp VC; Akcali KC; Arica MY
J Biomater Sci Polym Ed; 2014; 25(7):657-78. PubMed ID: 24580096
[TBL] [Abstract][Full Text] [Related]
15. An oral 2-hydroxypropyl-β-cyclodextrin-loaded spirooxindole-pyrrolizidine derivative restores p53 activity via targeting MDM2 and JNK1/2 in hepatocellular carcinoma.
Gao X; Wei M; Shan W; Liu Q; Gao J; Liu Y; Zhu S; Yao H
Pharmacol Res; 2019 Oct; 148():104400. PubMed ID: 31425749
[TBL] [Abstract][Full Text] [Related]
16. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
17. Thermosensitive multilayer hydrogels of poly(N-vinylcaprolactam) as nanothin films and shaped capsules.
Liang X; Kozlovskaya V; Chen Y; Zavgorodnya O; Kharlampieva E
Chem Mater; 2012 Aug; 24(19):3707-3719. PubMed ID: 23087543
[TBL] [Abstract][Full Text] [Related]
18. A new sponge-type hydrogel based on hyaluronic acid and poly(methylvinylether-alt-maleic acid) as a 3D platform for tumor cell growth.
Bucatariu SM; Constantin M; Varganici CD; Rusu D; Nicolescu A; Prisacaru I; Carnuta M; Anghelache M; Calin M; Ascenzi P; Fundueanu G
Int J Biol Macromol; 2020 Dec; 165(Pt B):2528-2540. PubMed ID: 33098901
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting.
Raza F; Zhu Y; Chen L; You X; Zhang J; Khan A; Khan MW; Hasnat M; Zafar H; Wu J; Ge L
Biomater Sci; 2019 Apr; 7(5):2023-2036. PubMed ID: 30839983
[TBL] [Abstract][Full Text] [Related]
20. A Chimeric Cetuximab-Functionalized Corona as a Potent Delivery System for Microtubule-Destabilizing Nanocomplexes to Hepatocellular Carcinoma Cells: A Focus on EGFR and Tubulin Intracellular Dynamics.
Poojari R; Kini S; Srivastava R; Panda D
Mol Pharm; 2015 Nov; 12(11):3908-23. PubMed ID: 26426829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
